Showing 621 - 640 results of 1,388 for search '"immunosuppression"', query time: 0.05s Refine Results
  1. 621

    Immunotherapy of osteosarcoma based on immune microenvironment modulation by Heping Lian, Heping Lian, Jiakui Zhang, Shuna Hou, Shuang Ma, Jiachen Yu, Wei Zhao, Duoyi Zhao, Zhiyu Zhang

    Published 2025-01-01
    “…As an emerging oncological treatment, immunotherapy has shown potential in the clinical management of many tumors but has a poor response rate in osteosarcoma. The immunosuppressive microenvironment in osteosarcoma is the main reason for the ineffectiveness of immunotherapy, in which the low immune response rate of immune effector cells and the high activation of immunosuppressive cells contribute to this outcome. …”
    Get full text
    Article
  2. 622

    Clinical Implications for the Timely Diagnosis of Mycobacterium marinum in the Age of Biologic Therapy: A Case Report and Review of the Literature by Chris J. Lata, Kelle Edgar, Stephen Vaughan

    Published 2017-01-01
    “…The natural history of this infection can be altered if the host is immunosuppressed, leading to disseminated presentations. …”
    Get full text
    Article
  3. 623

    Cyclosporin, Tacrolimus, Mycophenolic Acid, and Dexamethasone Suppress Peripheral Blood Mononuclear Cell Proliferation and Inhibit Interferon-Gamma, IL-10 and IL-13 Production <em>... by Abdel-Rahman Youssef

    Published 2024-12-01
    “…Objective: The primary goals of immunosuppressive therapy are to prevent graft rejection and to improve graft and patient survival. …”
    Get full text
    Article
  4. 624

    Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody by Yusho Ishii, Hiroshi Fujii, Koichiro Sugimura, Tsuyoshi Shirai, Yosuke Hoshi, Yoko Fujita, Yuko Shirota, Tomonori Ishii, Hiroaki Shimokawa, Hideo Harigae

    Published 2020-01-01
    “…In general, several vasodilators are used as therapeutic drugs for SSc-PAH, whereas immunosuppressive therapies are not. Here, we report the case of a 62-year-old female with anticentriole antibody-positive SSc-PAH treated with immunosuppressants and vasodilators. …”
    Get full text
    Article
  5. 625

    Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic by A. Klimašauskienė, R. Bunevičiūtė

    Published 2020-06-01
    “…During the COVID-19 pandemic, MG/LEMS patients should continue ongoing treatment and are advised not to stop any immunosuppressive agents used. Altering or stopping an immunosuppressive agent may increase disease activity and/or MG exacerbation or crisis. …”
    Get full text
    Article
  6. 626

    Pneumonia by Listeria monocytogenes: A Common Infection by an Uncommon Pathogen by Theocharis Koufakis, Marianneta Chatzopoulou, Anastasios Margaritis, Maria Tsiakalou, Ioannis Gabranis

    Published 2015-01-01
    “…Infections by Listeria monocytogenes typically occur in infants, the elderly, pregnant women, and immunosuppressed subjects. Pulmonary infections in adults are extremely uncommon and only few reports can be found in the literature. …”
    Get full text
    Article
  7. 627

    Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy by Saito Mayu, Sakiko Isojima, Yoko Miura, Shinichiro Nishimi, Mika Hatano, Takahiro Tokunaga, Ryo Takahashi, Keiko Koide, Yusuke Miwa

    Published 2019-01-01
    “…Polymyositis-dermatomyositis is extremely rare during pregnancy, and immunosuppressive therapy should be administered after carefully considering the effects on both the mother and fetus. …”
    Get full text
    Article
  8. 628

    Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease by Virginia Flores, Belén Rodríguez-Sánchez, Ignacio Marín-Jiménez, Emilio Bouza, Luis Menchén, Patricia Muñoz

    Published 2014-01-01
    “…A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.…”
    Get full text
    Article
  9. 629

    Spontaneous Pneumomediastinum due to Anti-Melanoma Differentiation-Associated Protein 5 Requiring a Bilateral Lung Transplant by Amrit Singh Jhajj, James Hok Shun Yeung, Fergus To

    Published 2021-01-01
    “…In medical literature, aggressive immunosuppressive therapy has been the mainstay of anti-MDA5-associated SPM management. …”
    Get full text
    Article
  10. 630

    Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors by Mei Zhan, Mei Zhan, Qinran Long, Qinran Long, Jinhan He, Jinhan He, Jinhan He, Litao Huang, Bin Wu, Bin Wu, Haixia Xu, Li Mo, Ting Xu

    Published 2025-01-01
    “…By excluding patients influenced by glucocorticoids or immunosuppressants, ICI-DM was observed in 713 of 8,199 (8.70%) patients. …”
    Get full text
    Article
  11. 631

    Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians by Muhammad Abdul Mabood Khalil, Muhammad Ashhad Ullah Khalil, Taqi F. Taufeeq Khan, Jackson Tan

    Published 2018-01-01
    “…On the contrary, reducing or stopping immunosuppressive medications in these events can provoke a rejection. …”
    Get full text
    Article
  12. 632

    Use of High-Flow Nasal Cannula Oxygen Therapy in a Pregnant Woman with Dermatomyositis-Related Interstitial Pneumonia by Tomohiro Shoji, Takeshi Umegaki, Kota Nishimoto, Natsuki Anada, Akiko Ando, Takeo Uba, Munenori Kusunoki, Kanako Oku, Takahiko Kamibayashi

    Published 2017-01-01
    “…In order to save the life of the patient, the use of combination therapy with immunosuppressants was necessary. The patient underwent emergency cesarean section and was immediately treated with immunosuppressants while continuing HFNC oxygen therapy. …”
    Get full text
    Article
  13. 633

    The changing landscape of treatment for acquired hemophilia A by Massimo Franchini, Daniele Focosi

    Published 2025-01-01
    “…Recent studies have renewed the interest towards the immunosuppressive agent rituximab for FVIII inhibitor eradication and have suggested a potential role for emicizumab for the prevention of bleeding in AHA patients. …”
    Get full text
    Article
  14. 634

    Dermatological Disorders following Liver Transplantation: An Update by Dipesh Kumar Yadav, Xue li Bai, Tingbo Liang

    Published 2019-01-01
    “…Patients undergoing liver transplantation (LT) are at a high risk of dermatological complications compared to the general population as a result of long-term use of immunosuppressant. However, the risk is not as high as other solid organ transplantations (SOT), particularly for skin cancer. …”
    Get full text
    Article
  15. 635

    CD24 is expressed in HNSCC and is correlated with a dampened immune response by Deborah C. Schubert, Marvin Hürter, Dimo Dietrich, Sebastian Strieth, Peter Brossart, Peter Altevogt, Christine Sanders, Glen Kristiansen

    Published 2024-06-01
    “…Purpose:: Recently, CD24 on tumor cells was identified as a phagocytic inhibitor contributing to an immunosuppressive tumor microenvironment via binding to Siglec-10 on macrophages. …”
    Get full text
    Article
  16. 636

    Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes by Yang Liu, Ke Zheng, Yecheng Liu, Huadong Zhu

    Published 2020-01-01
    “…Purpose. With immunosuppressants being widely used, Pneumocystis jirovecii pneumonia (PCP) has been increasing and could be life-threatening among HIV-negative patients. …”
    Get full text
    Article
  17. 637

    Ehrlichiosis in a Recent Liver Transplant Recipient Leading to Multiorgan Failure by Fawwaz Almajali, Catherine Oleary, Taylor Hallcox, Justin Lok, Daniela Hermelin, Alexis Guenette, Mustafa Nazzal

    Published 2022-01-01
    “…While Ehrlichia often presents as a mild form of the disease in immunocompetent patients, immunosuppressed patients are at increased risk for a more virulent and potentially fatal infection. …”
    Get full text
    Article
  18. 638

    Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case... by Yuka Ogawa, Dai Kishida, Yasuhiro Shimojima, Koichi Hayashi, Yoshiki Sekijima

    Published 2017-01-01
    “…Even after combination immunosuppressive therapy including a corticosteroid, cyclosporine A, and intravenous cyclophosphamide, his respiratory insufficiency and cutaneous involvement progressively worsened. …”
    Get full text
    Article
  19. 639

    Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata by Taisuke Ito

    Published 2013-01-01
    “…The HF is a unique “miniorgan” with its own immune and hormonal microenvironment. The immunosuppressive milieu of the anagen hair bulb modulated by immunosuppressive factors is known as “hair follicle immune privilege.” …”
    Get full text
    Article
  20. 640

    Case Report: Combined Autoimmune Pancreatitis, Ulcerative Colitis and Sclerosing Cholangitis in 28-y.o. Patient by A. R. Khurmatullina, A. V. Okhlobystin, L. N. Androsova, R. T. Rzayev, A. S. Tertychnyy, A. P. Kiryukhin, O. Z. Okhlobystina, M. S. Zharkova, O. S. Shifrin, V. T. Ivashkin

    Published 2025-02-01
    “…Colonic lesions that initially had low grade of inflammation were resistant to immunosuppressive therapy.Key points. A 28-year-old female patient was admitted to the clinic for jaundice associated with pruritis. …”
    Get full text
    Article